Tesamorelin 10mg

Tesamorelin 10mg | Growth Hormone-Releasing Hormone Analog | ≥99% Purity (HPLC)

Tesamorelin is a synthetic 44-amino-acid peptide analog of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoyl modification at the N-terminus for enhanced stability and potency. This FDA-approved research peptide (in certain contexts) is extensively studied for its selective stimulation of pituitary GH secretion, leading to increased IGF-1 levels and targeted effects on visceral adipose tissue.

Research investigations have demonstrated Tesamorelin’s ability to:

• Significantly reduce visceral abdominal fat accumulation
• Increase lean body mass and muscle density
• Improve lipid profiles and insulin sensitivity in specific models
• Enhance cognitive function and quality of life markers
• Support metabolic health in contexts of excess visceral adiposity
• Exhibit minimal impact on subcutaneous fat or overall body weight

Tesamorelin is of major interest in endocrinology, metabolic syndrome, HIV-associated lipodystrophy, and age-related body composition research due to its targeted lipolytic effects and favorable safety profile in clinical studies.

For Research Use Only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Strictly intended for in vitro laboratory research by qualified professionals.

Specifications:

• Sequence: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂
• Molecular Formula: C₂₂₁H₃₆₆N₆₄O₆₇S
• Molecular Weight: 5135.89 Da
• Appearance: White lyophilized powder
• Purity: ≥99% (HPLC)
• Solubility: Water-soluble
• Storage: Lyophilized at -20°C; reconstituted at 2–8°C short-term. Protect from light and moisture.

Common Research Areas: Visceral fat reduction • Growth hormone axis modulation • Metabolic syndrome • HIV lipodystrophy models • Body composition • IGF-1 signaling • Lipid metabolism • Endocrine regulation